INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Schedule of Components of Loss before Income Tax

The components of loss before provision for (benefit from) income taxes for the years ended December 31, 2022, 2021 and 2020, are as follows (in thousands):

	2022		2021		2020
Loss subject to domestic income taxes	$	(1,306,245)	$	(2,580,324)	$	(719,636)
Income subject to foreign income taxes	2,164		612		68
	$	(1,304,081)	$	(2,579,712)	$	(719,568)

Schedule of Components of Income Tax Expense (Benefit)

The Company recorded provision for (benefit from) income taxes in connection with its domestic, state, and foreign subsidiaries for the years ended December 31, 2022, 2021 and 2020, respectively, as follows (in thousands):

	2022		2021		2020
Current
Federal	$	—	$	18	$	—
State	14		4		5
Foreign	365		27		(193)
Total current tax expense (benefit)	$	379	$	49	$	(188)
Deferred
Federal	$	—	$	—	$	—
State	—		—		—
Foreign	—		—		—
Total deferred tax expense (benefit)	$	—	$	—	$	—
Total Provision for (benefit from) income taxes	$	379	$	49	$	(188)

Schedule of Effective Income Tax Rate Reconciliation

The reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes for the years ended December 31, 2022, 2021 and 2020 was as follows:

	Year Ended December 31,
	2022	2021	2020
Statutory federal income tax rate	21.0%	21.0%	21.0%
Stock-based compensation	(0.6)	(2.9)	(0.2)
Change in fair value of warrant liability	20.2	(8.5)	(3.4)
Tax-exempt interest	0.4	—	—
Nondeductible expenses	0.4	(0.3)	(0.1)
Tax credits	1.4	0.7	2.8
Change in valuation allowance	(42.8)	(10.0)	(20.1)
Provision for (benefit from) income taxes	—%	—%	—%

Schedule of Components of Deferred Tax Assets

Significant components of the Company’s deferred taxes as of December 31, 2022 and 2021, are as follows (in thousands):

	2022		2021
Deferred tax assets:
Net operating loss carryforwards	$	974,097	$	519,410
Tax credit carryforwards	104,678		71,783
Stock-based compensation expense	26,438		22,559
Capitalization of research and development costs	174,564		—
Accruals and reserves	100,622		59,894
Lease Liability	84,635		52,592
Other	19,037		8,547
Total deferred tax assets	1,484,071		734,785
Valuation allowance	(1,374,265)		(672,898)
Total deferred tax assets, net of valuation allowance	109,806		61,887
Deferred tax liabilities:
Depreciation	(39,618)		(20,180)
Right-of-use assets	(70,188)		(41,707)
Total deferred tax liabilities	(109,806)		(61,887)
Deferred tax assets (liabilities), net of valuation allowance	$	—	$	—

Schedule of Unrecognized Tax Benefits Roll Forward

The following table summarizes the activity related to unrecognized tax benefits for the years ended December 31, 2022, 2021 and 2020 (in thousands):

	December 31,
	2022		2021		2020
Unrecognized benefit—beginning of period	$	72,330	$	42,894	$	20,635
Gross increases—prior-period tax positions	—		—		21
Gross decreases—prior-period tax positions	—		—		(2)
Gross increases—current-period tax positions	32,916		31,336		22,382
Gross decrease—current-period tax positions	—		—		—
Statute lapse	(12)		(1,900)		(142)
Unrecognized benefit—end of period	$	105,234	$	72,330	$	42,894